Akari Therapeutics PLC (AKTX) vs Cellectar Biosciences, Inc. (CLRB)
Akari Therapeutics PLC and Cellectar Biosciences, Inc. are both Biotechnology companies. Cellectar Biosciences, Inc. is the larger, with a market value of $19.6M against $17.6M — 1.1× the size. Across the 10 metrics below, Cellectar Biosciences, Inc. leads on 7 and Akari Therapeutics PLC on 3.
Valuation
Profitability
| Metric | AKTX | CLRB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (140.09%) | (125.99%) | (57.72%) |
| Return on assets | (69.16%) | (88.70%) | (49.22%) |
| Return on invested capital | (167.93%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack